For this funding opportunity AMED and MRC define engineering biology as the process of taking synthetic biology concepts and translating them into real-world solutions. It is the design and fabrication of biological components and systems, from modifications of natural systems through to artificial biology. For the purposes of this activity, engineering biology refers to:
- the development or use of synthetic biology, using engineering principles, to design and fabricate biological components and systems
- the adoption of synthetic biology into industrial processes
- the development of tools and technologies that specifically support synthetic biology
Important note: Full details of the scope will be available at the launch of the joint funding opportunity in January 2024.
We will fund projects lasting three years.
This initiative will provide funding for up to three collaborative research projects. In total, MRC will make up to £3 million available in support of the UK components. Approximately 158 million JPY, in total for the three year period per research project, will be provided by the AMED in support of the planned Japanese research.
MRC will fund eligible costs applicable to the UK research requested by the UK project lead.
MRC will fund 80% of the full economic cost and 100% of permitted exceptions, related to the UK research costs.
The Japan-based project lead and associated costs for Japan-based research will be funded by AMED.
Find out more about full economic costing.